STOCK PLUMMETS AFTER NOVO NORDISK DEAL BREAKDOWN

Shares of HIMS experienced a dramatic decline today following the unexpected cancellation of its deal with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending HIMS's stock price plummeting by over fifteen percent. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate th